RE:RE:RE:RE:Danny's RantYes it would be great if the terms of the placement were better but don't forget what conditions the market are. There are not a lot of options for speculative companies. No one can raise money without dropping the shareprice. If they don't raise the money they loose credibility with the developement team. If what they have is a real it was the right move. If the drug turns out to be nothing of value then current shareholders would be better off if they did not raise the money and put developement and approval on standby. We all are investing in the hope it is real.